2,111 Shares in Universal Health Services, Inc. $UHS Bought by Petrus Trust Company LTA

Key Points

• Petrus Trust Company LTA acquired 2,111 shares of Universal Health Services, Inc. valued at approximately $397,000 during the first quarter.
• Universal Health Services reported $5.35 EPS for the quarter, exceeding analysts' expectations and showcasing a 9.6% revenue increase year-over-year.
• The company recently declared a quarterly dividend of $0.20 per share, representing an annualized yield of 0.4%.

Petrus Trust Company LTA purchased a new position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,111 shares of the health services provider's stock, valued at approximately $397,000.

A number of other institutional investors have also recently added to or reduced their stakes in UHS. AQR Capital Management LLC boosted its position in Universal Health Services by 57.8% during the 1st quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider's stock worth $173,381,000 after purchasing an additional 340,966 shares during the period. Ameriprise Financial Inc. boosted its position in Universal Health Services by 329.4% during the 1st quarter. Ameriprise Financial Inc. now owns 404,806 shares of the health services provider's stock worth $76,081,000 after purchasing an additional 310,531 shares during the period. Twinbeech Capital LP boosted its position in Universal Health Services by 1,151.1% during the 4th quarter. Twinbeech Capital LP now owns 152,454 shares of the health services provider's stock worth $27,353,000 after purchasing an additional 140,268 shares during the period. GAMMA Investing LLC boosted its position in Universal Health Services by 16,935.6% during the 1st quarter. GAMMA Investing LLC now owns 138,670 shares of the health services provider's stock worth $26,056,000 after purchasing an additional 137,856 shares during the period. Finally, Nuveen LLC purchased a new position in Universal Health Services in the 1st quarter valued at about $25,555,000. 86.05% of the stock is owned by hedge funds and other institutional investors.

Universal Health Services Stock Performance

Shares of UHS stock opened at $190.41 on Monday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.19 and a current ratio of 1.29. Universal Health Services, Inc. has a one year low of $152.33 and a one year high of $243.25. The company's 50-day simple moving average is $176.27 and its 200-day simple moving average is $178.41. The stock has a market capitalization of $12.12 billion, a price-to-earnings ratio of 10.03, a PEG ratio of 0.78 and a beta of 1.28.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The health services provider reported $5.35 EPS for the quarter, topping the consensus estimate of $4.85 by $0.50. Universal Health Services had a net margin of 7.66% and a return on equity of 18.25%. The business had revenue of $4.28 billion for the quarter, compared to analysts' expectations of $4.24 billion. During the same quarter last year, the company posted $4.31 earnings per share. The company's quarterly revenue was up 9.6% compared to the same quarter last year. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. Equities analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current fiscal year.

Universal Health Services Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Tuesday, September 2nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $0.80 annualized dividend and a dividend yield of 0.4%. Universal Health Services's dividend payout ratio (DPR) is presently 4.21%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on UHS. Royal Bank Of Canada upped their price objective on shares of Universal Health Services from $201.00 to $206.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 19th. Wall Street Zen raised shares of Universal Health Services from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 23rd. Robert W. Baird decreased their price objective on shares of Universal Health Services from $243.00 to $203.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Stephens raised shares of Universal Health Services to a "hold" rating in a research report on Monday, June 2nd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Universal Health Services from $215.00 to $195.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Four research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $214.77.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.